The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ

(2016) Marquita R. Decker et al.   ANNALS OF SURGICAL ONCOLOGY

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

(2016) Sylvain Ladoire et al.   Autophagy

Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer

(2016) Barbara Ingold Heppner et al.   Breast Care

Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

(2016) Jitka Fucikova et al.   CANCER RESEARCH

Microbiome and Anticancer Immunosurveillance

(2016) Laurence Zitvogel et al.   CELL

The Basis of Oncoimmunology

(2016) A. Karolina Palucka et al.   CELL

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

(2016) B. Ingold Heppner et al.   CLINICAL CANCER RESEARCH

The immune microenvironment of breast ductal carcinoma in situ

(2016) Elizabeth Thompson et al.   MODERN PATHOLOGY

CD8+tumor-infiltrating lymphocytes contribute to spontaneous “healing” in HER2-positive ductal carcinoma in situ

(2016) Michi Morita et al.   Cancer Medicine

Management of Ductal Carcinoma In Situ of the Breast

(2016) Chirag Shah et al.   JAMA Oncology

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

(2015) M. V. Dieci et al.   ANNALS OF ONCOLOGY

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

(2015) Carsten Denkert et al.   JOURNAL OF CLINICAL ONCOLOGY

Natural and therapy-induced immunosurveillance in breast cancer

(2015) Guido Kroemer et al.   NATURE MEDICINE

eIF2α phosphorylation as a biomarker of immunogenic cell death

(2015) Oliver Kepp et al.   SEMINARS IN CANCER BIOLOGY

Morphometric analysis of immunoselection against hyperploid cancer cells

(2015) Norma Bloy et al.   Oncotarget

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

(2015) Erika Vacchelli et al.   Oncotarget

Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells

(2015) Erika Vacchelli et al.   OncoImmunology

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy

(2014) Gautier Stoll et al.   OncoImmunology

Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

(2013) S. Rusakiewicz et al.   CANCER RESEARCH

Immunosurveillance against tetraploidization-induced colon tumorigenesis

(2013) Alice Boilève et al.   CELL CYCLE

Crosstalk between ER stress and immunogenic cell death

(2013) Oliver Kepp et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Pan-cancer patterns of somatic copy number alteration

(2013) Travis I Zack et al.   NATURE GENETICS

Cytoplasmic STAT3 Represses Autophagy by Inhibiting PKR Activity

(2012) Shensi Shen et al.   MOLECULAR CELL

An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

(2012) L. Senovilla et al.   SCIENCE

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells

(2012) Laura Senovilla et al.   OncoImmunology

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Illicit survival of cancer cells during polyploidization and depolyploidization

(2010) I Vitale et al.   CELL DEATH AND DIFFERENTIATION

Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia

(2010) M Wemeau et al.   Cell Death & Disease

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

(2009) Theocharis Panaretakis et al.   EMBO JOURNAL

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

(2009) Carsten Denkert et al.   JOURNAL OF CLINICAL ONCOLOGY